Essa Pharma Operating Income

Essa Pharma (EPIX) currently reports a operating income of $-15M as of June 2025. That compares with $-30M in the prior-year period — up 50.3% year over year. Use the charts on this page to explore Essa Pharma's operating income history and peer comparisons.

Essa Pharma's operating income increased from $-30M to $-15M — a 50.3% year-over-year increase (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Essa Pharma reported $-15M in operating income as of June 2025. That compares with $-30M in the prior-year period — up 50.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-15M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Essa Pharma, and consider following EPIX for alerts when major investors trade the stock.

Essa Pharma is classified in the Healthcare sector. On operating income, it currently shows $-15M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing EPIX with unrelated industries.